XML 54 R44.htm IDEA: XBRL DOCUMENT v3.24.0.1
COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)
12 Months Ended
Mar. 19, 2022
Feb. 15, 2022
Nov. 27, 2018
Aug. 15, 2018
Dec. 31, 2023
Dec. 31, 2022
Reimbursement or royalty         $ 0 $ 0
Contingent payments due         0  
Global and BioLife Sciences [Member]            
Sale of royalty percentage   20.00%        
Ownership percentage   20.00%        
Royalty Agreement [Member]            
Royalty percentage       50.00%    
Royalty Agreement [Member] | Chemia Corporation [Member]            
Royalty percentage       50.00%    
Sale of royalty percentage     5.00%      
License Agreement [Member]            
Sale of royalty percentage 5.50%          
Development cost, percent 50.00%          
Development costs $ 1,250,000          
Development costs, period cost         200,000 $ 0
Contingent legal fees         $ 0